Atlas Trials

Treatment of Malignant Tumors With NK Cell

Clinical trial NCT05143125 · UNKNOWN

Trial details

NCT number
NCT05143125
Sponsor
Shenzhen University General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignancy
Start date
2021-02-05
Primary completion
2024-02-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.